Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 1Osteosarcoma 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Mobility Limitation 1Melanoma 1Kidney Neoplasms 1Head and Neck Neoplasms 1Carcinoma, Transitional Cell 1COVID-19 1Breast Neoplasms 1

Interventions

Specimen Handling 8Magnetic Resonance Spectroscopy 7Biopsy 7pembrolizumab 6Doxorubicin 6Cyclophosphamide 6X-Rays 4Radiation 4Phantoms, Imaging 4Radiotherapy 3Nuclear Medicine Department, Hospital 3Irinotecan 3Ifosfamide 3ulixertinib 2tipifarnib 2selpercatinib 2pazopanib 2palbociclib 2liposomal doxorubicin 2ivosidenib 2fludarabine 2ensartinib 2atezolizumab 2Temozolomide 2Surveys and Questionnaires 2Gemcitabine 2Fluorodeoxyglucose F18 2Carboplatin 2Bevacizumab 2trifluridine tipiracil drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma × Patient Reported Outcome Measures × 30 days × Clear all
NCT07502885 2026-05-05

Deep Phenotyping Gait Deficits in Orthopedic Manifestations of Pediatric Cancer Patients

St. Jude Children's Research Hospital

Recruiting
300 enrolled
Sarcoma

Sarcoma, Osteosarcoma, Mobility Limitation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡